Form 8-K - Current report:
SEC Accession No. 0001558370-25-004150
Filing Date
2025-03-31
Accepted
2025-03-31 15:55:23
Documents
15
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20250331x8k.htm   iXBRL 8-K 42484
2 EX-99.1 dwtx-20250331xex99d1.htm EX-99.1 161350
3 GRAPHIC dwtx-20250331xex99d1002.jpg GRAPHIC 4807
  Complete submission text file 0001558370-25-004150.txt   343755

Data Files

Seq Description Document Type Size
4 EX-101.SCH dwtx-20250331.xsd EX-101.SCH 3396
5 EX-101.LAB dwtx-20250331_lab.xml EX-101.LAB 15926
6 EX-101.PRE dwtx-20250331_pre.xml EX-101.PRE 10041
17 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250331x8k_htm.xml XML 4852
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 25792921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)